Application of interpretable artificial neural networks to early monoclonal antibodies development

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Application of interpretable artificial neural networks to early monoclonal antibodies development. / Gentiluomo, Lorenzo; Roessner, Dierk; Augustijn, Dillen; Svilenov, Hristo; Kulakova, Alina; Mahapatra, Sujata; Winter, Gerhard; Streicher, Werner; Rinnan, Åsmund; Peters, Günther H. J.; Harris, Pernille; Friess, Wolfgang.

I: European Journal of Pharmaceutics and Biopharmaceutics, Bind 141, 2019, s. 81-89.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Gentiluomo, L, Roessner, D, Augustijn, D, Svilenov, H, Kulakova, A, Mahapatra, S, Winter, G, Streicher, W, Rinnan, Å, Peters, GHJ, Harris, P & Friess, W 2019, 'Application of interpretable artificial neural networks to early monoclonal antibodies development', European Journal of Pharmaceutics and Biopharmaceutics, bind 141, s. 81-89. https://doi.org/10.1016/j.ejpb.2019.05.017

APA

Gentiluomo, L., Roessner, D., Augustijn, D., Svilenov, H., Kulakova, A., Mahapatra, S., ... Friess, W. (2019). Application of interpretable artificial neural networks to early monoclonal antibodies development. European Journal of Pharmaceutics and Biopharmaceutics, 141, 81-89. https://doi.org/10.1016/j.ejpb.2019.05.017

Vancouver

Gentiluomo L, Roessner D, Augustijn D, Svilenov H, Kulakova A, Mahapatra S o.a. Application of interpretable artificial neural networks to early monoclonal antibodies development. European Journal of Pharmaceutics and Biopharmaceutics. 2019;141:81-89. https://doi.org/10.1016/j.ejpb.2019.05.017

Author

Gentiluomo, Lorenzo ; Roessner, Dierk ; Augustijn, Dillen ; Svilenov, Hristo ; Kulakova, Alina ; Mahapatra, Sujata ; Winter, Gerhard ; Streicher, Werner ; Rinnan, Åsmund ; Peters, Günther H. J. ; Harris, Pernille ; Friess, Wolfgang. / Application of interpretable artificial neural networks to early monoclonal antibodies development. I: European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; Bind 141. s. 81-89.

Bibtex

@article{5cb4cef50a8442cabcbf6ac61c67a925,
title = "Application of interpretable artificial neural networks to early monoclonal antibodies development",
keywords = "Neural network(s), Machine learning, Protein aggregation, Protein formulation, Monoclonal antibody, Stability",
author = "Lorenzo Gentiluomo and Dierk Roessner and Dillen Augustijn and Hristo Svilenov and Alina Kulakova and Sujata Mahapatra and Gerhard Winter and Werner Streicher and {\AA}smund Rinnan and Peters, {G{\"u}nther H. J.} and Pernille Harris and Wolfgang Friess",
year = "2019",
doi = "10.1016/j.ejpb.2019.05.017",
language = "English",
volume = "141",
pages = "81--89",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Application of interpretable artificial neural networks to early monoclonal antibodies development

AU - Gentiluomo, Lorenzo

AU - Roessner, Dierk

AU - Augustijn, Dillen

AU - Svilenov, Hristo

AU - Kulakova, Alina

AU - Mahapatra, Sujata

AU - Winter, Gerhard

AU - Streicher, Werner

AU - Rinnan, Åsmund

AU - Peters, Günther H. J.

AU - Harris, Pernille

AU - Friess, Wolfgang

PY - 2019

Y1 - 2019

KW - Neural network(s)

KW - Machine learning

KW - Protein aggregation

KW - Protein formulation

KW - Monoclonal antibody

KW - Stability

U2 - 10.1016/j.ejpb.2019.05.017

DO - 10.1016/j.ejpb.2019.05.017

M3 - Journal article

C2 - 31112768

VL - 141

SP - 81

EP - 89

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -

ID: 225831046